Journal
SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41598-021-02608-1
Keywords
-
Categories
Funding
- Brazilian Council for Scientific and Technological Development (CNPq
- Brasilia, Brazil)
- Rio de Janeiro State Research Foundation (FAPERJ
- Rio de Janeiro, Brazil) [E-26/010.101042/2018, E-26/010.002160/2019]
- CAPES, the Brazilian federal agency for graduate education
Ask authors/readers for more resources
Dexmedetomidine was found to have protective effects in both lung and brain tissues in rats with acute ischemic stroke, reducing inflammation and damage compared to untreated rats. Propofol, on the other hand, showed some negative effects, increasing expression of certain adhesion molecules in the lungs and brain. Dexmedetomidine also showed a greater reduction in inflammatory cytokines compared to propofol in alveolar macrophages and lung endothelial cells.
Acute ischemic stroke is associated with pulmonary complications, and often dexmedetomidine and propofol are used to decrease cerebral metabolic rate. However, it is unknown the immunomodulatory actions of dexmedetomidine and propofol on brain and lungs during acute ischemic stroke. The effects of dexmedetomidine and propofol were compared on perilesional brain tissue and lung damage after acute ischemic stroke in rats. Further, the mean amount of both sedatives was directly evaluated on alveolar macrophages and lung endothelial cells primarily extracted 24-h after acute ischemic stroke. In twenty-five Wistar rats, ischemic stroke was induced and after 24-h treated with sodium thiopental (STROKE), dexmedetomidine and propofol. Dexmedetomidine, compared to STROKE, reduced diffuse alveolar damage score [median(interquartile range); 12(7.8-15.3) vs. 19.5(18-24), p = 0.007)], bronchoconstriction index [2.28(2.08-2.36) vs. 2.64(2.53-2.77), p = 0.006], and TNF-alpha expression (p = 0.0003), while propofol increased VCAM-1 expression compared to STROKE (p = 0.0004). In perilesional brain tissue, dexmedetomidine, compared to STROKE, decreased TNF-alpha (p = 0.010), while propofol increased VCAM-1 compared to STROKE (p = 0.024). In alveolar macrophages and endothelial cells, dexmedetomidine decreased IL-6 and IL-1 beta compared to STROKE (p = 0.002, and p = 0.040, respectively), and reduced IL-1 beta compared to propofol (p = 0.014). Dexmedetomidine, but not propofol, induced brain and lung protection in experimental acute ischemic stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available